Viva Biotech, Shandong Gold eye HK IPOs
China's Viva Biotech Holdings is planning to float on the Hong Kong Stock Exchange, having filed a draft prospectus with the bourse on Monday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: